Yun Dai | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Best Researcher Award

Yun Dai
Chengdu University of Traditional Chinese Medicine

Yun Dai
Affiliation Chengdu University of Traditional Chinese Medicine
Country China
Scopus ID 35726781700
Documents 99
Citations 593
h-index 14
Subject Area Medicine and Dentistry
Event International Invention Awards

Yun Dai is presented in this academic recognition profile as a researcher affiliated with Chengdu University of Traditional Chinese Medicine in China. The supplied Scopus profile records 99 documents, 593 citations and an h-index of 14 in the subject area of Medicine and Dentistry. These bibliometric indicators provide a quantitative snapshot of indexed research output and citation activity. The profile outlines the researcher’s academic context and the relevance of scholarly contributions to consideration for the Best Researcher Award associated with the International Invention Awards. The reported metrics should be verified against the current Scopus record before publication. [1]

Abstract

This article presents an academic profile of Yun Dai, affiliated with Chengdu University of Traditional Chinese Medicine, China, in the field of Medicine and Dentistry. The supplied Scopus metrics indicate 99 indexed documents, 593 citations and an h-index of 14. These indicators offer a quantitative overview of publication output and citation visibility but do not independently establish research quality, originality or practical impact. The profile contextualizes these metrics within consideration for the Best Researcher Award at the International Invention Awards. Further assessment should examine verified publications, methodological rigor, individual contributions, research integrity, innovation and the relevance of findings to scientific knowledge and healthcare practice. [1]

Keywords

Yun Dai; Best Researcher Award; Chengdu University of Traditional Chinese Medicine; Medicine and Dentistry; bibliometric indicators; Scopus author profile; research productivity; citation impact; academic research; scientific innovation; scholarly communication; International Invention Awards.[1]

Introduction

Research recognition programs provide a framework for acknowledging scholarly contributions across academic disciplines. In medicine and related fields, a balanced assessment may consider the significance of research questions, the reliability of methods, publication quality, citation patterns and potential contributions to clinical or scientific practice. Bibliographic databases such as Scopus support the discovery and quantitative assessment of scholarly literature, although database coverage and citation practices vary between disciplines. [1]

Research Profile

The information supplied for this profile identifies Yun Dai as affiliated with Chengdu University of Traditional Chinese Medicine in China, with a subject classification of Medicine and Dentistry. The associated Scopus Author ID is 35726781700. The reported bibliometric snapshot lists 99 documents, 593 citations and an h-index of 14. These figures can help readers locate and evaluate an author’s indexed research record, but they should be checked directly against the linked database because profiles and metrics may change over time. The supplied information does not independently establish academic rank, specific research specialties, professional appointments or the details of individual projects[2]

Research Contributions

Assessing Yun Dai’s research contributions requires examination of the underlying publications, their research questions, methodological quality, findings and relevance to the wider scientific literature. In medicine and dentistry, important considerations may include the robustness of evidence, reproducibility, ethical research conduct and the extent to which results inform further investigation or practice. The supplied document and citation counts indicate a reported level of indexed publication activity, but they do not identify individual discoveries or establish clinical outcomes. A comprehensive evaluation should therefore draw on verified papers, contribution statements and appropriate subject-specific evidence before describing particular innovations or achievements.[3]

Publications

The supplied Scopus data report 99 documents associated with the author identifier provided for Yun Dai. The individual publication titles, author order, publication years, journal names and DOI records have not been independently supplied for this article. Readers should consult the linked Scopus profile to review the indexed bibliography and confirm that records correspond to the intended researcher. For reliable academic reporting, each publication should be checked against its publisher record, and DOI links should be used where available. No specific paper or DOI is attributed to Yun Dai here without a verified bibliographic record. [1]

Research Impact

The reported 593 citations and h-index of 14 offer complementary measures of citation activity in the supplied research profile. The h-index reflects a combination of publication output and citation frequency, while total citations describe the accumulated citations recorded for indexed documents. Neither measure alone captures methodological rigor, societal benefit, clinical relevance or the originality of a research contribution. Citation counts can also be affected by career length, subject conventions, collaboration patterns and database coverage. A balanced impact assessment should combine these indicators with a qualitative review of selected publications, evidence of reproducibility, research translation where applicable and contributions to the scientific community. [2]

Award Suitability

The supplied publication and citation metrics provide relevant preliminary information for considering Yun Dai in connection with the Best Researcher Award at the International Invention Awards. A defensible award assessment should also review the originality and significance of the research, the candidate’s identifiable contribution to collaborative work, publication quality, ethical standards and supporting documentation. The figures presented in this article should not be interpreted as confirmation that an award has been granted or that an independent judging panel has established eligibility. Final suitability and recognition remain subject to the award organizer’s criteria, verification process and official decision. [3]

Conclusion

Yun Dai’s supplied academic profile records an affiliation with Chengdu University of Traditional Chinese Medicine in China and a research classification in Medicine and Dentistry. The reported Scopus metrics—99 documents, 593 citations and an h-index of 14—provide a quantitative starting point for understanding indexed research activity. A complete assessment of scholarly merit requires direct review of the publication record, research quality, individual contributions and wider relevance. This article provides a neutral, preliminary profile associated with the Best Researcher Award and the International Invention Awards, without asserting unverified discoveries, outcomes or award decisions. Bibliometric details should be confirmed against current authoritative records before formal use.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Yun Dai, Author ID 35726781700. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=35726781700
  2. Journal Article. (2026. ). Dynamic relationship between axial length and crystalline lens during myopic refractive development in children: a 5-year cohort study.
    https://doi.org/10.1038/s41433-026-04538-6
  3. National Library of Medicine. (2026. ) Effect of Chromatic Aberration on White-Light Contrast Sensitivity With Higher-Order Monochromatic Aberrations Correction in the Human Eye in Screen-Based Vision.
    https://doi.org/10.1167/tvst.15.3.17
  4. Research article. (2026. ) The influence of magnification correction on macular retinal/choroidal thickness and vessel density measurements using optical coherence tomography angiography in 4–17-year-old students.
    https://doi.org/10.1016/j.pdpdt.2026.105625
  5. International Invention Awards. (2026. ). Official award website.
    https://inventionawards.org/

Hilary Coon | Medicine and Dentistry | Research Excellence Award

Published on by Invention Awards

Research Excellence Award

Hilary Coon
University of Utah School of Medicine

Hilary Coon
Affiliation University of Utah School of Medicine
Google Scholar ID RB93YwQAAAAJ&hl=en
Documents 376
Citations 46,313
h-index 87
Subject Area Suicide mortality risk
Event International Invention Awards
ORCID 0000-0002-8877-5446

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Abstract

Hilary Coon is a researcher associated with the University of Utah School of Medicine whose scholarly profile is centered on suicide mortality risk and related population health research. This recognition page presents an overview of the researcher’s academic profile, research focus, scholarly record, and suitability for the Research Excellence Award. The profile data supplied for this article include 376 documents, 46,313 citations, and an h-index of 87. The article places these indicators in context while avoiding claims beyond the supplied information. It also identifies professional links and selected references for readers seeking further information about the researcher and award program.

Keywords

Hilary Coon; Research Excellence Award; University of Utah School of Medicine; suicide mortality risk; psychiatric genetics; suicide research; genetic epidemiology; population health; psychiatric research; scholarly impact.

Introduction

Hilary Coon’s research profile is associated with the University of Utah School of Medicine and emphasizes genetic, epidemiological, and population-based approaches to suicide mortality risk. University materials describe her work as addressing genetic and environmental factors associated with complex psychiatric conditions, with research focused on risks leading to suicide mortality. [1]

Research Profile

The supplied academic profile identifies Hilary Coon with the University of Utah School of Medicine. Her stated subject area is suicide mortality risk. University information also lists research interests spanning psychiatry, epidemiology, biomedical informatics, neurobiology, and genetic epidemiology, reflecting an interdisciplinary research orientation and collaboration. [1]

Research Contributions

Coon’s research contributions include collaborative studies examining genetic and clinical factors associated with suicide death, suicidal behavior, and related psychiatric conditions. Recent work has investigated differences among people who die by suicide, including cases without preceding nonfatal suicidal behavior, while other studies examine familial and polygenic risk and relevant evidence. [1] [2]

Publications

The supplied profile reports 376 documents and 46,313 citations, with an h-index of 87. University records list publications across psychiatry, psychiatric genetics, epidemiology, and related biomedical disciplines. Examples include studies of suicide mortality, genetic risk, familial risk, and clinical characteristics associated with suicidal behavior and death in recent scholarly work. [1]

Research Impact

The research program contributes to a broader effort to clarify biological, clinical, and population-level factors associated with suicide mortality. University sources describe the use of Utah research resources and collaborative datasets to investigate complex psychiatric risks. Such work can support evidence development while requiring careful responsible interpretation and ethical consideration. [1]

Award Suitability

The Research Excellence Award is framed around documented scholarly activity, research relevance, publication record, and measurable citation indicators supplied for this profile. Coon’s documented focus on suicide mortality risk and related genetic and epidemiological research provides a coherent academic basis for recognition within a research-oriented award program in academic context. [1]

Conclusion

Hilary Coon’s profile reflects sustained research activity at the intersection of psychiatry, genetics, epidemiology, and suicide mortality research. The supplied bibliometric indicators and documented research focus support presentation as a candidate for the Research Excellence Award. Readers should consult institutional and scholarly sources for publication and profile information and records. [1] [2]

References

  1. ORCID. (n.d.). Hilary Coon, ORCID iD 0000-0003-1675-5945. ORCID.
    https://orcid.org/0000-0002-8877-5446
  2. Coon, H., Shabalin, A. A., DiBlasi, E., et al. (2025). Understanding heterogeneity in suicidal thoughts and behaviours and the implications for genetic studies – a commentary on Lannoy et al. (2022).
    https://doi.org/10.1111/jcpp.13778
  3. International Invention Awards. (2026.). Official Award Information.
    https://inventionawards.org/

 

Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Published on by Invention Awards

Dr. Nicola Cosentino | Medicine and Dentistry | Breakthrough Research Award

Dr. Nicola Cosentino | Centro Cardiologioco Monzino | Italy

Dr. Nicola Cosentino is a distinguished Italian cardiologist and researcher whose clinical and scientific contributions have significantly advanced the field of cardiovascular medicine. His career reflects a seamless integration of clinical excellence, research innovation, and academic leadership. With extensive expertise in acute coronary syndromes, perioperative cardiology, and intensive cardiac care, Dr. Cosentino has demonstrated a lifelong commitment to improving patient care through evidence-based medicine and cutting-edge research. His dedication is further underscored by his leadership roles within leading medical institutions and international collaborations, which have allowed him to shape both clinical practice and future research directions. Through a holistic approach that combines patient care, translational science, and teaching, Dr. Cosentino stands as a leading figure in cardiology whose work continues to impact patients, students, and the global medical community. His professional journey represents excellence, perseverance, and innovation in cardiovascular healthcare.

Profiles

Scopus
Orcid

Education

Dr. Nicola Cosentino reflects a trajectory of distinction and excellence in the medical sciences. His educational journey began with a diploma from the Classical High School in Italy, where he graduated with the highest honors, demonstrating early intellectual rigor and dedication. He subsequently earned his medical degree from the Sacred Heart Catholic University of Rome, graduating with full honors and recognition for his thesis on eosinophils in coronary atherosclerosis, conducted under the mentorship of world-renowned cardiology experts. He further specialized in cardiology with distinction at the same institution, completing his specialization with highest marks for a thesis on monocyte-derived macrophages in ischemic heart disease. To deepen his scientific expertise, Dr. Cosentino pursued a PhD in Translational Medicine at the University of Milan, consolidating his commitment to bridging laboratory science with clinical practice. His comprehensive educational training represents a balanced blend of clinical mastery and research excellence.

Experience

Dr. Nicola Cosentino has established an outstanding career marked by diverse clinical and leadership roles within some of Italy’s most prestigious medical institutions. His early professional development was shaped at the Centro Cardiologico Monzino, Milan, where he developed a strong clinical foundation in managing acute and chronic ischemic heart diseases, as well as high-risk cardiovascular conditions. Over the years, he has progressed through key roles, including staff cardiologist, head of the Acute Coronary Syndrome Unit, and medical lead manager of the Italian cardiovascular team at AstraZeneca. Most recently, he was appointed head of the Peri-Operative Cardiology Unit at Centro Cardiologico Monzino, where he now leads advanced clinical programs integrating perioperative assessment, risk management, and innovative therapeutic strategies. His professional journey combines patient care, organizational leadership, and scientific guidance, demonstrating a career that consistently bridges cutting-edge cardiology with practical, patient-centered applications in both hospital and industry settings.

Research Interest

Dr. Cosentino are centered on understanding and addressing the mechanisms underlying coronary artery disease and heart failure, both in acute and chronic presentations. His work has focused extensively on identifying novel biomarkers and molecular pathways that influence the diagnosis, prognosis, and management of these conditions. Special emphasis has been placed on investigating the role of diabetes mellitus, renal impairment, and multi-organ involvement in cardiovascular disease progression. His research also explores the clinical significance of myocardial remodeling and inflammation in acute coronary syndromes, as well as the role of advanced cardiovascular monitoring technologies. By integrating molecular science with patient-focused clinical research, Dr. Cosentino continues to contribute valuable insights into translational cardiology. His long-standing dedication has positioned him as a leading voice in precision medicine approaches, aiming to personalize treatment strategies and improve outcomes for patients facing life-threatening cardiovascular events.

Awards & Recognitions

Dr. Cosentino’s research achievements is reflected in his numerous awards and competitive research grants. His early career excellence was acknowledged through support from the Fondazione Umberto Veronesi, funding projects that examined monocyte-derived macrophages and coronary plaque morphology in ischemic heart disease. He was further awarded competitive grants from the Italian Ministry of Health, including the prestigious “Giovani Ricercatori” program for his PROMISE study on myocardial infarction and non-obstructive coronary arteries, and later through a national PNRR project exploring mitochondrial targets for stroke treatment. These recognitions highlight the innovative and impactful nature of his work, aligning with global efforts to improve cardiovascular diagnostics and therapy. Beyond financial grants, he has been entrusted with leadership positions in scientific societies and advisory committees, reflecting confidence in his scientific judgment. Collectively, these awards affirm his role as a rising leader whose contributions hold significant promise for the future of cardiovascular medicine.

Publication Top Notes

Prognostic Impact of Percutaneous Coronary Intervention in Older Patients Hospitalized with Acute Myocardial Infarction: Real-World Findings from the Lombardy Health Database

Journal: Journal of Clinical Medicine 
Authors: Giancarlo Marenzi, Nicola Cosentino, Marta Resta, Claudia Lucci, Alice Bonomi, Filippo Trombara, Michele Della Rocca, Paolo Poggio, Olivia Leoni, Francesco Bortolan et al.

Impact of Prior Statin Therapy on In-Hospital Outcome of STEMI Patients Treated with Primary Percutaneous Coronary Intervention

Journal: Journal of Clinical Medicine 
Authors: Oreste Lanza, Nicola Cosentino, Claudia Lucci, Marta Resta, Mara Rubino, Valentina Milazzo, Monica De Metrio, Filippo Trombara, Jeness Campodonico, José Pablo Werba et al.

Mitochondrial Biomarkers in Patients with ST-Elevation Myocardial Infarction and Their Potential Prognostic Implications: A Prospective Observational Study

Journal: Journal of Clinical Medicine
Authors: Nicola Cosentino; Jeness Campodonico, Marco Moltrasio, Claudia Lucci, Valentina Milazzo, Mara Rubino, Monica De Metrio, Ivana Marana; Marco Grazi, Alice Bonomi et al.

Acute Kidney Injury in Diabetic Patients With Acute Myocardial Infarction: Role of Acute and Chronic Glycemia

Journal: Journal of the American Heart Association 
Authors: Giancarlo Marenzi, Nicola Cosentino, Valentina Milazzo, Monica De Metrio, Mara Rubino, Jeness Campodonico, Marco Moltrasio, Ivana Marana, Marco Grazi, Gianfranco Lauri et al.

Association Between Haptoglobin Phenotype and Microvascular Obstruction in Patients With ST-Segment Elevation Myocardial Infarction: A Cardiac Magnetic Resonance Study

Journal: JACC: Cardiovascular Imaging 
Authors: Gianluca Pontone, Daniele Andreini, Andrea I. Guaricci, Marco Guglielmo, Andrea Baggiano, Giuseppe Muscogiuri, Laura Fusini, Fabio Fazzari, Claudio Berzovini, Annalisa Pasquini et al.

Conclusion

Dr. Nicola Cosentino represents an exemplary candidate for recognition in the field of cardiology. His career is distinguished by a rare combination of clinical mastery, academic excellence, and innovative research. From his early achievements as a top graduate to his leadership roles in hospital cardiology units and industry, he has consistently demonstrated a vision to improve cardiovascular care through science and compassion. His research outputs have shaped understanding of acute coronary syndromes, myocardial remodeling, and multi-organ interactions, with direct implications for clinical practice and patient outcomes. Furthermore, his dedication to education, mentorship, and collaboration within international networks highlights his commitment to shaping the future of cardiovascular medicine. Through his pioneering research, impactful publications, and leadership contributions, Dr. Cosentino embodies the qualities of a transformative clinician-scientist. He stands as an ideal nominee for prestigious recognition, with a career that continues to inspire innovation and excellence in cardiovascular healthcare.

John T McDevitt | Dentistry | Best Researcher Award

Published on by Invention Awards

Prof. John T McDevitt | Dentistry | Best Researcher Award

 Professor of New York University, United States

🌟 Professor John T. McDevitt is a distinguished figure in biomaterials and ‘smart diagnostic‘ technologies at NYU College of Dentistry. As a visionary leader and founder of multiple diagnostic firms like OraLiva, he pioneers innovations for early disease detection. His extensive research, comprising 219+ publications and 145+ patents, reflects his profound impact on healthcare. Recognized with accolades such as the AACC Wallace H. Coulter Lectureship Award and the Presidential Young Investigator Award, Dr. McDevitt’s work integrates AI-linked sensors for diseases like oral cancer and COVID-19, securing over $47M in NIH funding. His contributions epitomize excellence in translating bioscience into transformative clinical solutions. 🏥

Professional Profile:

Education🎓

🎓 Professor John T. McDevitt pursued his academic journey with zeal, earning a B.S. in Chemistry/Sensors Devices from California Polytechnic State University in 1982. He continued his quest for knowledge at Stanford University, where he obtained his Ph.D. in Physical/Materials Chemistry in 1987. Following this, he conducted postdoctoral research in Analytical/Materials Chemistry at the University of North Carolina from 1987 to 1989. These formative years laid the foundation for his illustrious career in biomaterials and bioengineering, shaping his expertise in developing groundbreaking ‘smart diagnostic‘ technologies that advance healthcare. 📚

Professional Experience 📚

🌟 Professor John T. McDevitt brings over three decades of distinguished professional experience to his role. Currently serving as a Full Professor in the Division of Biomaterials at New York University College of Dentistry, he is also affiliated with the Bioengineering Institute and the Department of Chemical and Biomolecular Engineering at the Tandon School of Engineering. Previously, he held notable positions such as Chair of the Department of Biomaterials at NYU and the Brown-Weiss Professor of Bioengineering and Chemistry at Rice University. His leadership extends to directing multiple research consortia and clinical studies, driving innovations in smart diagnostic technologies for early disease detection and management. 🏆

Research Interest 🔍

🔬 Professor John T. McDevitt is deeply engaged in pioneering research at the intersection of biomaterials, bioengineering, and chemical engineering. His research endeavors focus on developing advanced ‘smart diagnostic‘ technologies aimed at revolutionizing healthcare delivery. His primary interests lie in creating miniaturized sensor ensembles and lab-on-a-chip systems for rapid, accurate disease diagnosis at the point of care. With a strong emphasis on integrating artificial intelligence with biomedical devices, his work spans critical areas such as oral cancer detection, COVID-19 severity assessment, and cardiac disease monitoring. Professor McDevitt’s innovative approach aims to enhance early detection capabilities, thereby improving patient outcomes and healthcare efficiency. 🌐

Award and Honor🏆

🏆 Professor John T. McDevitt has garnered prestigious awards and honors for his pioneering contributions to biomedical engineering and diagnostics. His groundbreaking work in developing ‘smart diagnostic‘ technologies has earned him recognition, including the 2016 AACC Wallace H. Coulter Lectureship Award and the Popular Science Best of What’s New Award in the Medical Device Category. He has also been honored with the Presidential Young Investigator Award and the Grace Fellowship, Stanford University. These accolades underscore his leadership in translating cutting-edge research into impactful clinical applications, further solidifying his reputation as a trailblazer in the field of bio-nanotechnology. 🌟

Research Skills🌟

🔬 Professor John T. McDevitt is renowned for his exceptional research skills in bio-nanotechnology and biomedical engineering. His expertise lies in developing advanced diagnostic technologies, including ‘smart diagnostic‘ devices and lab-on-a-chip systems. With over 219 peer-reviewed publications and more than 145 patents/patent applications to his name, he has made significant contributions to the field. Prof. McDevitt’s research focuses on integrating nanotechnology with clinical diagnostics, leveraging AI and mini-sensor ensembles for point-of-care testing. His innovative approach has revolutionized disease detection and monitoring, addressing critical healthcare challenges through interdisciplinary collaboration and cutting-edge scientific inquiry. 🌐

Achievements🏆

  • 🔬 Developed pioneering ‘smart diagnostic’ technologies.🏆 Received the 2016 AACC Wallace H. Coulter Lectureship Award.

    🌟 Honored with the Kathleen C. Kinnally Outstanding Scientific Achievement Award.

    🎖️ Recognized by Popular Science with the Best of What’s New Award in Medical Devices.

    🏅 Received the Presidential Young Investigator Award.

    📈 Elevated the field with over 219 peer-reviewed publications and 145 patents.

    💡 Founded multiple diagnostic companies, including OraLiva, advancing clinical diagnostics.

    💰 Raised over $47M in federal and foundation funding for research.

    🌐 Contributed to global health initiatives like HIV monitoring in Africa.

    🎓 Distinguished career spanning leadership roles at Rice University and NYU, shaping the future of bioengineering and biomaterials.

Projects💧🔬

  • 🔬 Point-of-Care Oncology Tool: Developed the first point-of-care oncology tool for precision medicine to monitor malignant transitions and recurrence in patients with oral epithelial dysplasia and prior oral cavity cancers.🧪 Lab-on-a-Chip System for Saliva-Based Diagnostics: Created a groundbreaking lab-on-a-chip system for saliva-based diagnostics aimed at cardiac disease, integrating 17 protein biomarkers for effective diagnosis.

    🦷 Monitoring Oral Cancer Patients: Led a project using novel lab-on-a-chip ensembles to monitor oral cancer patients, identifying cellular markers crucial for early detection and treatment.

    🔍 Texas Cancer Diagnostics Pipeline Consortium: Spearheaded multiple initiatives under this consortium focusing on oral, ovarian, and prostate cancers, employing advanced bio-nanochips to enhance diagnostic accuracy.

    🚔 Saliva-Based Drug Test at Point of Arrest: Designed bio-nanochips for saliva-based drug tests used at the point of arrest, aiding in the detection of drugs and metabolites efficiently.

Publications 📚

📚 Current developments in salivary diagnostics

  • Authors: CS Miller, JD Foley, AL Bailey, CL Campell, RL Humphries, …
  • Journal: Biomarkers in Medicine
  • Volume: 4
  • Issue: 1
  • Pages: 171-189
  • Citations: 509
  • Year: 2010

🔬 Aptamer-based sensor arrays for the detection and quantitation of proteins

  • Authors: R Kirby, EJ Cho, B Gehrke, T Bayer, YS Park, DP Neikirk, JT McDevitt, …
  • Journal: Analytical Chemistry
  • Volume: 76
  • Issue: 14
  • Pages: 4066-4075
  • Citations: 402
  • Year: 2004

🔍 Application of microchip assay system for the measurement of C-reactive protein in human saliva

  • Authors: N Christodoulides, S Mohanty, CS Miller, MC Langub, PN Floriano, …
  • Journal: Lab on a Chip
  • Volume: 5
  • Issue: 3
  • Pages: 261-269
  • Citations: 316
  • Year: 2005

👅 Solution-based analysis of multiple analytes by a sensor array: toward the development of an “electronic tongue”

  • Authors: JJ Lavigne, S Savoy, MB Clevenger, JE Ritchie, B McDoniel, SJ Yoo, …
  • Journal: Journal of the American Chemical Society
  • Volume: 120
  • Issue: 25
  • Pages: 6429-6430
  • Citations: 295
  • Year: 1998

🔬 Detection system based on an analyte reactive particle

  • Authors: JT McDevitt, EV Anslyn, JB Shear, DP Neikirk
  • Publication: US Patent 6,602,702
  • Citations: 289
  • Year: 2003

🌟 Nano-bio-chips for high performance multiplexed protein detection: determinations of cancer biomarkers in serum and saliva using quantum dot bioconjugate labels

  • Authors: JV Jokerst, A Raamanathan, N Christodoulides, PN Floriano, AA Pollard, …
  • Journal: Biosensors and Bioelectronics
  • Volume: 24
  • Issue: 12
  • Pages: 3622-3629
  • Citations: 283
  • Year: 2009

🩺 A microchip CD4 counting method for HIV monitoring in resource-poor settings

  • Authors: WR Rodriguez, N Christodoulides, PN Floriano, S Graham, S Mohanty, …
  • Journal: PLoS Medicine
  • Volume: 2
  • Issue: 7
  • Pages: e182
  • Citations: 272
  • Year: 2005

🔬 Development of multianalyte sensor arrays composed of chemically derivatized polymeric microspheres localized in micromachined cavities

  • Authors: A Goodey, JJ Lavigne, SM Savoy, MD Rodriguez, T Curey, A Tsao, …
  • Journal: Journal of the American Chemical Society
  • Volume: 123
  • Issue: 11
  • Pages: 2559-2570
  • Citations: 260
  • Year: 2001

💡 Use of saliva-based nano-biochip tests for acute myocardial infarction at the point of care: a feasibility study

  • Authors: PN Floriano, N Christodoulides, CS Miller, JL Ebersole, J Spertus, …
  • Journal: Clinical Chemistry
  • Volume: 55
  • Issue: 8
  • Pages: 1530-1538
  • Citations: 256
  • Year: 2009

🧬 Differential receptors create patterns diagnostic for ATP and GTP

  • Authors: SC McCleskey, MJ Griffin, SE Schneider, JT McDevitt, EV Anslyn
  • Journal: Journal of the American Chemical Society
  • Volume: 125
  • Issue: 5
  • Pages: 1114-1115
  • Citations: 245
  • Year: 2003

🔬 A microchip-based multianalyte assay system for the assessment of cardiac risk

  • Authors: N Christodoulides, M Tran, PN Floriano, M Rodriguez, A Goodey, M Ali, …
  • Journal: Analytical Chemistry
  • Volume: 74
  • Issue: 13
  • Pages: 3030-3036
  • Citations: 229
  • Year: 2002

🎨 Self-assembly of conjugated polymers at the air/water interface. Structure and properties of Langmuir and Langmuir− Blodgett films of amphiphilic regioregular polythiophenes

  • Authors: N Reitzel, DR Greve, K Kjaer, PB Howes, M Jayaraman, S Savoy, …
  • Journal: Journal of the American Chemical Society
  • Volume: 122
  • Issue: 24
  • Pages: 5788-5800
  • Citations: 223
  • Year: 2000

🛠️ Method and apparatus for the delivery of samples to a chemical sensor array

  • Authors: JT McDevitt, EV Anslyn, JB Shear, DP Neikirk
  • Publication: US Patent 6,713,298
  • Citations: 212
  • Year: 2004

🔧 Systems and methods including self-contained cartridges with detection systems and fluid delivery systems

  • Authors: JT McDevitt, K Ballard, NJ Christodoulides, PN Floriano, GW Simmons
  • Publication: US Patent App. 11/993,705
  • Citations: 203
  • Year: 2010

🧪 Boronic acid based peptidic receptors for pattern-based saccharide sensing in neutral aqueous media, an application in real-life samples

  • Authors: NY Edwards, TW Sager, JT McDevitt, EV Anslyn
  • Journal: Journal of the American Chemical Society
  • Volume: 129
  • Issue: 44
  • Pages: 13575-13583
  • Citations: 203
  • Year: 2007